Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Market Access

Medicare weight loss drug pilot on ice as insurers decline to contribute

 April 22, 2026

Pharmaceutical Technology

The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027.

Market AccessMetabolic & GLP-1Read full story

Post navigation

Revolution drug shows promise in early pancreatic cancer →
← FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com